Protagonist Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Protagonist Therapeutics, Inc.‘s stocks are currently a part of 137 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 50.64M shares of Protagonist Therapeutics, Inc.. Compared to the previous quarter, the number grew by 2.43% or 1.20M shares more. As for the holding position changes, 39.42% (54) of current hedge fund investors increased the number of shares held, 32.12% (44) of current holders sold a part of the shares held, and 21.9% (30) closed the holdings completely. 21 hedge funds are new holders of Protagonist Therapeutics, Inc. stock in Q1 2022, it is 15.33% of total holders.
Hedge funds holding Protagonist Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 42 |
|---|---|
| Q3 2017 | 41 |
| Q4 2017 | 65 |
| Q1 2018 | 68 |
| Q2 2018 | 69 |
| Q3 2018 | 62 |
| Q4 2018 | 66 |
| Q1 2019 | 65 |
| Q2 2019 | 67 |
| Q3 2019 | 75 |
| Q4 2019 | 81 |
| Q1 2020 | 76 |
| Q2 2020 | 85 |
| Q3 2020 | 92 |
| Q4 2020 | 129 |
| Q1 2021 | 127 |
| Q2 2021 | 138 |
| Q3 2021 | 130 |
| Q4 2021 | 147 |
| Q1 2022 | 137 |
Hedge funds changes in Protagonist Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 7 | 18 | 10 | 5 | 2 |
|---|---|---|---|---|---|
| Q3 2017 | 6 | 16 | 9 | 7 | 3 |
| Q4 2017 | 27 | 28 | 5 | 3 | 2 |
| Q1 2018 | 17 | 31 | 15 | 13 | -8 |
| Q2 2018 | 19 | 25 | 21 | 18 | -14 |
| Q3 2018 | 11 | 20 | 25 | 17 | -11 |
| Q4 2018 | 15 | 16 | 30 | 9 | -4 |
| Q1 2019 | 12 | 26 | 23 | 14 | -10 |
| Q2 2019 | 15 | 30 | 16 | 12 | -6 |
| Q3 2019 | 17 | 29 | 18 | 9 | 2 |
| Q4 2019 | 18 | 34 | 15 | 12 | 2 |
| Q1 2020 | 8 | 30 | 27 | 10 | 1 |
| Q2 2020 | 26 | 41 | 14 | 17 | -13 |
| Q3 2020 | 20 | 30 | 32 | 13 | -3 |
| Q4 2020 | 47 | 48 | 21 | 10 | 3 |
| Q1 2021 | 25 | 43 | 41 | 26 | -8 |
| Q2 2021 | 27 | 60 | 35 | 16 | 0 |
| Q3 2021 | 25 | 58 | 33 | 31 | -17 |
| Q4 2021 | 34 | 59 | 35 | 18 | 1 |
| Q1 2022 | 21 | 54 | 44 | 30 | -12 |
Hedge funds changes in Protagonist Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 1,000 | 7,000 |
| Q4 2020 | 214,000 | 901,000 |
| Q1 2021 | 810,000 | 1,123,000 |
| Q2 2021 | 1,108,000 | 2,347,000 |
| Q3 2021 | 25,853,000 | 15,123,000 |
| Q4 2021 | 46,257,000 | 19,920,000 |
| Q1 2022 | 52,890,000 | 14,732,000 |